1 / 13

Acute Asthma in Adults

Acute Asthma in Adults. Tintinalli Chapter 72. Asthma definition. Chronic inflammatory disorder characterized by increased responsiveness of the airways to multiple stimuli Abnormal accumulation of eosinophils , lymphocytes, mast cells, macrophages. Pathophysiology.

pegeen
Télécharger la présentation

Acute Asthma in Adults

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Acute Asthma in Adults Tintinalli Chapter 72

  2. Asthma definition • Chronic inflammatory disorder characterized by increased responsiveness of the airways to multiple stimuli • Abnormal accumulation of eosinophils, lymphocytes, mast cells, macrophages

  3. Pathophysiology • Reduction in airway diameter • Smooth muscle contraction • Vascular congestion • Bronchial wall edema • Thickened secretions • Consequences • Air trapping (intrinsic PEEP) • Increased work of breathing • V/Q imbalance w/ resulting hypercapnea/hypoxia

  4. Clinical features • Classic triad • Dyspnea • Wheezing ( may be absent in severe cases) • Cough • Other sxs • Chest tightness • Prolonged expiration • Accessory muscle use • Tachypnea • Paradoxical abd breathing* • AMS* *signs of impending resp failure

  5. Disorders w/ wheezing may mimic asthma • CHF “cardiac asthma” • Upper airway obstruction • FB aspiration • Multiple pulmonary emboli • Vocal cord dysfunction • Pneumonia

  6. Key elements of history in asthma exacerbations • Present management and medications • Hospital admissions for exacerbations • ER visit in past year/month for exacerbations • Exposure to asthma triggers • Use of home peak flow meters • Best way to predict future exacerbation before it occurs • History of intubations/ICU admissions

  7. diagnosis • PEF (Peak Expiratory Flow) • Can determine severity and response to therapy if pt is cooperative • Assess hypoxemia • Pulse ox • ABG • Indicated in severe exacerbation to assess hypercapnea and acidosis. • CXR unnecessary unless indicated by physical exam findings

  8. Treatment • Goal- reverse airway obstruction • Adrenergic agents • β-adrenergic agents preferred as initial tx for bronchospasm • Albuterol, xopenex (continuous/intermittent) • Common side effects • Tachycardia • Nervousness/anxiety • Palpitations • Insomnia • Tremors

  9. Treatment (cont) • Corticosteroids • IV solumedrol 125mg • PO prednisone 40-60mg • Mechanism unknown, but benefit believed to be from • Effect to restore β-adrenergic responsiveness • Anti-inflammatory effects • Evidence suggests that steroid given within 1 hour of arrival to ED reduces need for hospitalization

  10. Treatment (cont) • Anticholinergics • Can be given to pt in form of nebulized treatment alone or in combination with β-adrenergic (additive) • Magnesium • Indicated for severe asthma exacerbation. • 1-2g IV over 30 min • Mechanical ventilation • Required pts who • Have signs of impending resp failure • Fail NIPPV • Does not resolve airflow obstruction, but reduces work of breathing

  11. Treatment (cont) • Evidence does not support use of the following for acute exacerbations: • Heliox • Theophylline • Mast Cell Modifiers • Leukotriene Inhibitors • Ketamine and Halothane

  12. Disposition • Decision to admit pt vs. discharge to home should be based on • Resolution of wheezing and improvement in air exchange • Pt with PEFR ≥ 70% predicted can be safely discharged to home. • Decision should also be guided by past/recent admissions for exacerbation indicating poor control/compliance • Poor response to treatment: Admit • FEV1 or PEF <40% predicted

  13. Disposition • Checklist for ED Discharge • MDI • Short acting B-agonist • Inhaled corticosteroid (studies show ↓ relapse rate) • Oral Steroid • Peak Flow Meter • PCP follow up • Action plan

More Related